APA (7th ed.) Citation

AL, O., ZA, C., SK, Q., RS, P., C, B., AR, M., . . . SJ, S. R. (2022). Prophylactic evaluation of verubecestat on disease- and symptom-modifying effects in 5XFAD mice. Alzheimer's & dementia (New York, N. Y.), 8(1), e12317. https://doi.org/10.1002/trc2.12317

Chicago Style (17th ed.) Citation

AL, Oblak, et al. "Prophylactic Evaluation of Verubecestat on Disease- and Symptom-modifying Effects in 5XFAD Mice." Alzheimer's & Dementia (New York, N. Y.) 8, no. 1 (2022): e12317. https://doi.org/10.1002/trc2.12317.

MLA (9th ed.) Citation

AL, Oblak, et al. "Prophylactic Evaluation of Verubecestat on Disease- and Symptom-modifying Effects in 5XFAD Mice." Alzheimer's & Dementia (New York, N. Y.), vol. 8, no. 1, 2022, p. e12317, https://doi.org/10.1002/trc2.12317.